Product Name: CDH19 Antibody
Species Reactivity: Human
Tested Applications: IHC-P, WB
Applications: For WB starting dilution is: 1:1000For IHC-P starting dilution is: 1:10~50
User Note: Optimal dilutions for each application to be determined by the researcher.
Predicted Molecular Weight: 87 kDa
Immunogen: This CDH19 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 613-640 amino acids from the C-terminal region of human CDH19.
Host Species: Rabbit
Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.
Physical State: Liquid
CAS NO.: 141505-33-1
Product: Levosimendan
Buffer: Supplied in PBS with 0.09% (W/V) sodium azide.
Concentration: 0.5 mg/ml
Storage Conditions: Store at 4˚C for three months and -20˚C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Clonality: Polyclonal
Conjugate: Unconjugated
Alternate Names: Cadherin-19, CDH19, CDH7L2
Accession NO.: Q9H159
Protein Ino: 17366818
Official Symbol: CDH19
Geneid: 28513
Background: This gene is a type II classical cadherin from thecadherin superfamily and one of three cadherin 7-like genes locatedin a cluster on chromosome 18. The encoded membrane protein is acalcium dependent cell-cell adhesion glycoprotein comprised of fiveextracellular cadherin repeats, a transmembrane region and a highlyconserved cytoplasmic tail. Type II (atypical) cadherins aredefined based on their lack of a HAV cell adhesion recognitionsequence specific to type I cadherins. Since disturbance ofintracellular adhesion is a prerequisite for invasion andmetastasis of tumor cells, cadherins are considered primecandidates for tumor suppressor genes.
PubMed ID:http://aac.asm.org/content/35/8/1547.abstract
